DAPSONE 8.5% / NIACINAMIDE 2% / SPIRONOLACTONE 5%- spironolactone, dapsone and niacinamide gel
Sincerus Florida, LLC
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Directions for use
Sincerus Florida, LLC. Adverse reactions
Active, inactive
NDC 72934-1064-2 DAPSONE USP 8.5% / NIACINAMIDE USP 2% / SPIRONOLACTONE USP 5%. Gel 30gm
DAPSONE 8.5% / NIACINAMIDE 2% / SPIRONOLACTONE 5%
dapsone 8.5% / niacinamide 2% / spironolactone 5% gel |
|
|
|
|
|
|
Revised: 05/2019 Sincerus Florida, LLC
RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.
https://rxdruglabels.com/lib/rx/rx-meds/dapsone-8-5-niacinamide-2-spironolactone-5/